Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS
Two separate studies at ACC.25 explored data from the EARLY TAVR trial. One analysis included stroke findings that surprised researchers.
Dapagliflozin improves outcomes for elderly TAVR patients with heart failure
The positive data were presented as part of a late-breaking clinical trial at ACC.25 in Chicago. One cardiologist on stage for the presentation said these findings will impact the way he manages certain TAVR patients.
American Heart Association program leads to substantial improvements in stroke care
Cardiologist Gregg Fonarow, MD, reviewed decades of data and discussed the long-term impact of the AHA's Get With The Guidelines-Stroke program.
Bringing state-of-the-art healthcare to Florida heart patients
Naples Comprehensive Health is building up what it hopes will be a nationally recognized cardiology program. Robert Cubeddu, MD, and Dee Dee Wang, MD, spoke with Cardiovascular Business about the journey so far.
Society of Interventional Radiology seeks to bolster research funding for the specialty
During their annual meeting being held this week in Nashville, the society announced the launch of the SIR Foundation Endowment.

The new solutions were designed to help users during diagnostic, interventional and endovascular procedures.

The long-term impacts of COVID-19 infection aren’t well known, and the National Institutes of Health (NIH) plans to change that.

The classifier was developed using imaging data from nearly 2,000 patients.

The Food and Drug Administration has taken a non-stance when it comes to recommending COVID-19 booster shots.

Vizient is also working closely with the two companies to boost patient care.

Researchers tracked data from the UK Biobank study, sharing their analysis in the Journal of the American College of Cardiology.

It was important for researchers to confirm these stents didn't increase a patient's long-term risk of adverse events.

The study's authors hope their work can help high-risk patients receive the care they need.